ライフサイエンスコーパス: nicotinic acetylcholine receptor

1 negative allosteric modulator at the alpha7 nicotinic acetylcholine receptor.

2 pete with (123)I-5-IA for binding to beta(2)-nicotinic acetylcholine receptor.

3 ges in the gating conformational change of a nicotinic acetylcholine receptor.

4 s mediated by GABAA receptors in addition to nicotinic acetylcholine receptors.

5 sion to overcome imidacloprid binding to the nicotinic acetylcholine receptors.

6 ounds targeting the cannabinoid 1 and alpha7 nicotinic acetylcholine receptors.

7 that act as partial agonists at alpha4beta2-nicotinic acetylcholine receptors.

8 ellate origin that are potent antagonists of nicotinic acetylcholine receptors.

9 o acts as a positive allosteric modulator of nicotinic acetylcholine receptors.

10 a genetic mutation in RIC3; a chaperone for nicotinic acetylcholine receptors.

11 The molecular determinants that govern nicotinic acetylcholine receptor (AChR) assembly and tra

12 sociated with adult-type mouse neuromuscular nicotinic acetylcholine receptor (AChR) channel gating h

13 The distribution of nicotinic acetylcholine receptor (AChR) clusters at the

14 is (MG) without detectable antibodies to the nicotinic acetylcholine receptor (AChR) or to muscle-spe

15 le-channel currents recorded from the muscle nicotinic acetylcholine receptor (AChR), we have recentl

16 Nicotinic acetylcholine receptors (AChRs) mediate signal

17 Adult-type nicotinic acetylcholine receptors (AChRs) mediate signal

18 The number of nicotinic acetylcholine receptors (AChRs) present in the

19 Nicotinic acetylcholine receptors (AChRs) switch on/off

20 y Ab-mediated autoimmune responses to muscle nicotinic acetylcholine receptors (AChRs) that impair ne

21 a novel function of alphakap in stabilizing nicotinic acetylcholine receptors (AChRs).

22 Encenicline is a novel, selective alpha7 nicotinic acetylcholine receptor agonist in development

23 ently used in human therapy (benzimidazoles, nicotinic acetylcholine receptor agonists, macrocyclic l

24 ed transcripts of several targets, including nicotinic acetylcholine receptor alpha 1 and alpha 2 sub

25 Cloning of rye reveals that it encodes a nicotinic acetylcholine receptor alpha subunit required

26 d alpha3- and beta4-subunit-containing human nicotinic acetylcholine receptors (alpha3beta4*-nAChRs).

27 Two alpha4beta2 nicotinic acetylcholine receptor (alpha4beta2-nAChR) iso

28 novel radiotracer that binds to alpha4beta2 nicotinic acetylcholine receptors (alpha4beta2-nAChRs) a

29 ly, a decrease in the numbers of alpha4beta2 nicotinic acetylcholine receptors (alpha4beta2-nAChRs) i

30 Explorations into the alpha6-containing nicotinic acetylcholine receptors (alpha6* nAChRs) as pu

31 agus nerve regulation of splenic cholinergic nicotinic acetylcholine receptor alpha7 (nAChRa7) signal

32 i-inflammatory cytokines, adenosine, and the nicotinic acetylcholine receptor alpha7 subunit (alpha7n

33 (Abeta) accumulation in BMEC through Alpha7 nicotinic acetylcholine receptor (alpha7 nAChR).

34 tes lung cancer proliferation via the alpha7-nicotinic acetylcholine receptor (alpha7-nAChR) subtype.

35 SY5Y cells stably overexpressing the alpha-7 nicotinic acetylcholine receptor (alpha7-nAChR), a poten

36 ation in normal and cancer cells, the alpha7 nicotinic acetylcholine receptor (alpha7-nAChR), was mor

37 ent evidence suggests that activating alpha7 nicotinic acetylcholine receptors (alpha7 nAChR) may fac

38 f acetylcholine, which interacts with alpha7 nicotinic acetylcholine receptors (alpha7 nAChR) on immu

39 inding affinities and selectivity for alpha7-nicotinic acetylcholine receptors (alpha7-nAChRs) (Ki =

40 how that calcium-permeable alpha7-containing nicotinic acetylcholine receptors (alpha7-nAChRs), capab

41 a, where there are genetic insults in alpha7 nicotinic acetylcholine receptors (alpha7-nAChRs).

42 We examined alpha7beta2-nicotinic acetylcholine receptor (alpha7beta2-nAChR) exp

43 unique, distinct, and human-specific alpha7-nicotinic acetylcholine receptor (alpha7nAChR) gene [CHR

44 We hypothesized that agonism on alpha7 nicotinic acetylcholine receptor (alpha7nAChR) in fetal

45 The native alpha7 nicotinic acetylcholine receptor (alpha7nAChR) is a homo

46 Here, we show that ILC2s express the alpha7-nicotinic acetylcholine receptor (alpha7nAChR), which is

47 f amyloid-beta(42) (Abeta(42)) by the alpha7-nicotinic acetylcholine receptor (alpha7nAChR), which re

48 septal cholinergic fibers through the alpha7-nicotinic acetylcholine receptor (alpha7nAChR), whose ac

49 uced anti-shock effect via activating alpha7 nicotinic acetylcholine receptor (alpha7nAChR).

50 y and ischemia through stimulation of alpha7 nicotinic acetylcholine receptors (alpha7nAChR) on monon

51 c anti-inflammatory pathway (CAP) and alpha7 nicotinic acetylcholine receptors (alpha7nAChR).

52 that resulted from local blockade of alpha7-nicotinic acetylcholine receptors (alpha7nAChR).

53 n the reward circuitry of the brain, alpha-7-nicotinic acetylcholine receptors (alpha7nAChRs) modulat

54 the integration of neural signals and alpha7 nicotinic acetylcholine receptors (alpha7nAChRs) on sple

55 ells in mice that lack the alpha9 subunit of nicotinic acetylcholine receptors (alpha9 KO mice) alter

56 may, by increasing activation of the alpha7-nicotinic acetylcholine receptor, alter the development

57 he extracellular domain of the native alpha7 nicotinic acetylcholine receptor and acetylcholine bindi

58 t cytisine, a partial agonist that binds the nicotinic acetylcholine receptor and is used for smoking

59 RV fibrosis, RV inflammation, and RV alpha-7 nicotinic acetylcholine receptor and muscarinic acetylch

60 It irreversibly inhibits nicotinic acetylcholine receptors and allosterically int

61 Amniotic choline activates fetal alpha7-nicotinic acetylcholine receptors and facilitates develo

62 Using alpha4beta2 nicotinic acetylcholine receptors and the alpha4beta2-se

63 Expression of nicotinic (alpha-7 nicotinic acetylcholine receptor) and muscarinic (muscar

64 endocytosis (neural cell adhesion molecule, nicotinic acetylcholine receptor, and p75 neurotrophin r

65 pproached by sensory nerve fibers expressing nicotinic acetylcholine receptors, and intraurethral app

66 receptor antagonist), and chlorisondamine (a nicotinic acetylcholine receptor antagonist) were applie

67 n a cholinergic input because application of nicotinic acetylcholine receptor antagonists impairs thi

68 Neuronal alpha4beta2 nicotinic acetylcholine receptors are attractive drug ta

69 Nicotinic acetylcholine receptors are ligand-gated ion c

70 Several lines of evidence suggest nicotinic acetylcholine receptors as common sites of act

71 t on human voltage-gated calcium channels or nicotinic acetylcholine receptors at 5 muM.

72 howed significantly lower (21%-26%) beta(2)*-nicotinic acetylcholine receptor availability relative t

73 In vivo estimation of beta(2)-nicotinic acetylcholine receptor availability with molec

74 the availability of beta2-subunit-containing nicotinic acetylcholine receptors (beta2*-nAChR) in subj

75 moking partly by binding to beta2-containing nicotinic acetylcholine receptors (beta2*-nAChRs) in the

76 on of high-affinity beta2-subunit-containing nicotinic acetylcholine receptors (beta2*-nAChRs).

77 Through deletion of beta2 subunits of nicotinic acetylcholine receptors (beta2-nAChRs) selecti

78 d excitatory transmission was blocked by the nicotinic acetylcholine receptor blocker mecamylamine.

79 MS stem from molecular defects in the muscle nicotinic acetylcholine receptor, but they can also be c

80 ha7nAChR) gene [CHRNA7 (gene-encoding alpha7-nicotinic acetylcholine receptor)] called CHRFAM7A (gene

81 Nicotinic acetylcholine receptors can be assembled from

82 itive allosteric modulators (PAMs) of alpha7 nicotinic acetylcholine receptors can enhance ion channe

83 s16969968 that alters function of the alpha5 nicotinic acetylcholine receptor (CHRNA5) and noncoding

84 Neuronal nicotinic acetylcholine receptors containing alpha4, bet

85 1beta release in human and rat monocytes via nicotinic acetylcholine receptors containing subunits al

86 During chronic nicotine exposure, nicotinic acetylcholine receptors containing the beta4 s

87 te smoke (SS), or secondhand smoke, promoted nicotinic acetylcholine receptor-dependent exacerbation

88 clothianidin, but not imidacloprid, causes a nicotinic acetylcholine receptor-dependent rapid mitocho

89 The alpha7 nicotinic acetylcholine receptor, encoded by the CHRNA7

90 ation of antiinflammatory effects via alpha7 nicotinic acetylcholine receptor-expressing splenic macr

91 ters = primary outcome variables) as well as nicotinic acetylcholine receptor expression, muscle mass

92 level of nonsmokers following stimulation of nicotinic acetylcholine receptors (familywise error-corr

93 r organophosphates and methylcarbamates, the nicotinic acetylcholine receptor for neonicotinoids, the

94 s denatured at a higher temperature than the nicotinic acetylcholine receptor from Torpedo californic

95 model, based on the partial structure of the nicotinic acetylcholine receptor from Torpedo marmorata,

96 pamine neurons receive cholinergic input via nicotinic acetylcholine receptors from the Kenyon cells;

97 ent models have demonstrated that the alpha5 nicotinic acetylcholine receptor gene (CHRNA5) is import

98 The alpha7 nicotinic acetylcholine receptor gene (CHRNA7) is linked

99 Genetic variants in the nicotinic acetylcholine receptor gene family jointly con

100 enes revealed significant association of the nicotinic acetylcholine receptor gene family with both i

101 CHRNA7, the alpha7-nicotinic acetylcholine receptor gene, has been associat

102 ling of the joint effect of all 61 SNPs in 7 nicotinic acetylcholine receptor genes revealed signific

103 d the joint associations of 61 tag SNPs in 7 nicotinic acetylcholine receptor genes with subclinical

104 information for each of the family members, nicotinic acetylcholine receptors, glycine receptors, GA

105 interaction between beta-amyloid (Abeta) and nicotinic acetylcholine receptors has been widely studie

106 alpha7-Nicotinic acetylcholine receptors have emerged as a pote

107 allosteric modulators (PAMs) of alpha4beta2 nicotinic acetylcholine receptors have the potential to

108 ncluding electron microscopic studies of the nicotinic acetylcholine receptor, high-resolution X-ray

109 studies have found that acute stimulation of nicotinic acetylcholine receptors improves cognition in

110 eta2 subunits are the most abundant class of nicotinic acetylcholine receptor in the brain.

111 ore, phosphomimetic Dok-7 mutants aggregated nicotinic acetylcholine receptors in C2C12 myotubes with

112 ular junction, rapsyn, enables clustering of nicotinic acetylcholine receptors in high concentration

113 texts that predict alcohol, and suggest that nicotinic acetylcholine receptors in the NAc are critica

114 based on homology with the Torpedo marmorata nicotinic acetylcholine receptor infer the existence of

115 ure-based design of drugs targeting specific nicotinic acetylcholine receptor interfaces.

116 ression of naturally expressed mouse alpha6*-nicotinic acetylcholine receptors (malpha6*-nAChRs; wher

117 Isoform-specific mechanisms of alpha3beta4*-nicotinic acetylcholine receptor modulation by the proto

118 l impact of hydrogen bonding on human alpha7 nicotinic acetylcholine receptor (nAChR) activation and

119 er cognitive processes that are modulated by nicotinic acetylcholine receptor (nAChR) activation by c

120 ositive allosteric modulator (PAM) of alpha7 nicotinic acetylcholine receptor (nAChR) activation by o

121 linical trials suggest that drugs that alter nicotinic acetylcholine receptor (nAChR) activity can af

122 hether extending plasma levels of the alpha7-nicotinic acetylcholine receptor (nAChR) agonist 3-(2,4-

123 ystemic administration of the partial alpha7 nicotinic acetylcholine receptor (nAChR) agonist SSR 180

124 Among them is epibatidine, a nicotinic acetylcholine receptor (nAChR) agonist that is

125 ation of nicotine or ABT-418, an alpha4beta2 nicotinic acetylcholine receptor (nAChR) agonist, normal

126 Nicotinic acetylcholine receptor (nAChR) agonists augmen

127 The partial alpha4/alpha6/beta2* nicotinic acetylcholine receptor (nAChR) agonists vareni

128 CHRNA3-CHRNA5-CHRNB4 cluster coding for the nicotinic acetylcholine receptor (nAChR) alpha3, alpha5

129 imilarly, Abeta exposure increases levels of nicotinic acetylcholine receptor (nAChR) alpha7 subunit

130 Conotoxin GeXIVA inhibits the alpha9alpha10 nicotinic acetylcholine receptor (nAChR) and is analgesi

131 The nicotinic acetylcholine receptor (nAChR) and the acetylc

132 d as binding proteins, the Torpedo marmorata nicotinic acetylcholine receptor (nAChR) and the Lymnaea

133 These effects were blocked by the nicotinic acetylcholine receptor (nAChR) antagonist meca

134 alpha-Conotoxins, as nicotinic acetylcholine receptor (nAChR) antagonists, ar

135 The nicotinic acetylcholine receptor (nAChR) belongs to a su

136 The alpha7 nicotinic acetylcholine receptor (nAChR) belongs to the

137 Nicotinic acetylcholine receptor (nAChR) blockers potent

138 Nicotinic acetylcholine receptor (nAChR) cell surface ex

139 Enhancement of nicotinic acetylcholine receptor (nAChR) function may ha

140 Genetic variants in the nicotinic acetylcholine receptor (nAChR) genes have been

141 t promote a desensitized state of the alpha7 nicotinic acetylcholine receptor (nAChR) have been assoc

142 associate with this soluble surrogate of the nicotinic acetylcholine receptor (nAChR) in a cooperativ

143 The nicotinic acetylcholine receptor (nAChR) is a major targ

144 Although the activity of the nicotinic acetylcholine receptor (nAChR) is exquisitely

145 The alpha4beta2 nicotinic acetylcholine receptor (nAChR) is important in

146 The alpha4beta2 nicotinic acetylcholine receptor (nAChR) is the most abu

147 vity relationships for a new class of alpha7 nicotinic acetylcholine receptor (nAChR) modulators base

148 The novel nicotinic acetylcholine receptor (nAChR) mutation alphaC

149 on clinical trials, comparing varenicline, a nicotinic acetylcholine receptor (nAChR) partial agonist

150 Although the Torpedo nicotinic acetylcholine receptor (nAChR) reconstituted i

151 overexpression was via the alpha7 subunit of nicotinic acetylcholine receptor (nAChR) stimulation and

152 y a critical role in the characterization of nicotinic acetylcholine receptor (nAChR) structure and f

153 The nicotinic acetylcholine receptor (nAChR) subtype alpha6b

154 A is both an antagonist of the alpha9alpha10 nicotinic acetylcholine receptor (nAChR) subtype and an

155 Activation of the alpha3beta4 nicotinic acetylcholine receptor (nAChR) subtype has rec

156 ha-Conotoxin AuIB is a selective alpha3beta4 nicotinic acetylcholine receptor (nAChR) subtype inhibit

157 The alpha3beta4 nicotinic acetylcholine receptor (nAChR) subtype is wide

158 Nicotinic acetylcholine receptor (nAChR) subtypes are ex

159 n mice harboring a null mutant allele of the nicotinic acetylcholine receptor (nAChR) subunit gene al

160 ut and gain-of-function of specific neuronal nicotinic acetylcholine receptor (nAChR) subunit genes.

161 ar domain (ECD) of the human neuronal alpha2 nicotinic acetylcholine receptor (nAChR) subunit in comp

162 d withdrawal are separate processes and that nicotinic acetylcholine receptor (nAChR) upregulation un

163 The alpha9alpha10 nicotinic acetylcholine receptor (nAChR) was first ident

164 s for CHRNA7, the gene coding for the alpha7 nicotinic acetylcholine receptor (nAChR), and manifest a

165 CHRNA7, encoding for the alpha7 nicotinic acetylcholine receptor (nAChR), has been sugge

166 Partial agonists of the alpha4beta2 nicotinic acetylcholine receptor (nAChR), such as vareni

167 s not affect the activity against the alpha7 nicotinic acetylcholine receptor (nAChR), whereas its re

168 Consistently, the rank-order of blockade of nicotinic acetylcholine receptor (nAChR)-stimulated inwa

169 modulators (PAMs) acting on the human alpha7 nicotinic acetylcholine receptor (nAChR).

170 Positive allosteric modulators (PAMs) of nicotinic acetylcholine receptors (nAChR) are important

171 tional regulation and synaptic clustering of nicotinic acetylcholine receptors (nAChR) during neurotr

172 r behavior and, specifically, recruitment of nicotinic acetylcholine receptors (nAChR) in mesencephal

173 Neonicotinoid insecticides target nicotinic acetylcholine receptors (nAChR) in the nervous

174 ificant associations between variants in the nicotinic acetylcholine receptors (nAChR) subunits and n

175 Nicotine binds to nicotinic acetylcholine receptors (nAChR), which can exi

176 nositol anchor and modulates the activity of nicotinic acetylcholine receptors (nAChR).

177 ttes, accelerates cell proliferation through nicotinic acetylcholine receptors (nAChR).

178 nd murine monocytes by a mechanism involving nicotinic acetylcholine receptors (nAChR).

179 Inactivation of 42 genes, including the nicotinic acetylcholine receptors nAChRalpha1 and nAChRa

180 ly inhibit human alpha3beta2 and alpha6beta2 nicotinic acetylcholine receptor (nAChRs) and not the cl

181 ial agonist at alpha4beta2* and alpha6beta2* nicotinic acetylcholine receptors (nAChRs) and a full ag

182 First, Dalpha7 nicotinic acetylcholine receptors (nAChRs) and AP-1 are

183 compound NS3861 and cytisine are agonists of nicotinic acetylcholine receptors (nAChRs) and both bind

184 Nicotinic acetylcholine receptors (nAChRs) and gamma-ami

185 Both nicotinic acetylcholine receptors (nAChRs) and muscarini

186 The medial habenula (MHb) densely expresses nicotinic acetylcholine receptors (nAChRs) and participa

187 alpha4beta2 nicotinic acetylcholine receptors (nAChRs) are abundantl

188 Nicotinic acetylcholine receptors (nAChRs) are expressed

189 Neuronal nicotinic acetylcholine receptors (nAChRs) are ligand-ga

190 Nicotinic acetylcholine receptors (nAChRs) are oligomeri

191 Nicotinic acetylcholine receptors (nAChRs) are pentameri

192 Neuronal nicotinic acetylcholine receptors (nAChRs) are promising

193 and intensive study over the last 20 years, nicotinic acetylcholine receptors (nAChRs) are still far

194 Nicotinic acetylcholine receptors (nAChRs) are targets o

195 Nicotinic acetylcholine receptors (nAChRs) are the molec

196 Mesolimbic alpha6* nicotinic acetylcholine receptors (nAChRs) are thought t

197 alpha7 nicotinic acetylcholine receptors (nAChRs) are ubiquitou

198 The alpha7 nicotinic acetylcholine receptors (nAChRs) are uniquely

199 The alpha4beta2 nicotinic acetylcholine receptors (nAChRs) are widely ex

200 Nicotinic acetylcholine receptors (nAChRs) assemble in t

201 Nicotinic acetylcholine receptors (nAChRs) belong to the

202 Nicotinic acetylcholine receptors (nAChRs) bind nicotine

203 Nicotinic acetylcholine receptors (nAChRs) binding to th

204 ubset of cold thermosensors expressed alpha7 nicotinic acetylcholine receptors (nAChRs) but not other

205 Neuronal nicotinic acetylcholine receptors (nAChRs) containing th

206 ives significant cholinergic innervation and nicotinic acetylcholine receptors (nAChRs) contribute gr

207 ng the most widely co-abused substances, and nicotinic acetylcholine receptors (nAChRs) contribute to

208 ctive compounds that desensitize alpha4beta2 nicotinic acetylcholine receptors (nAChRs) could provide

209 P2X receptors and nicotinic acetylcholine receptors (nAChRs) display funct

210 All nicotinic acetylcholine receptors (nAChRs) evolved from

211 andoxin and shows high binding affinity with nicotinic acetylcholine receptors (nAChRs) expressed on

212 menthol enhances nicotine-induced changes in nicotinic acetylcholine receptors (nAChRs) expressed on

213 anatomical localisation and function of the nicotinic acetylcholine receptors (nAChRs) formed by the

214 Nicotinic acetylcholine receptors (nAChRs) have been inv

215 Antagonists of alpha9alpha10 nicotinic acetylcholine receptors (nAChRs) have been pro

216 The alpha6-containing nicotinic acetylcholine receptors (nAChRs) have recently

217 There is much interest in alpha7 nicotinic acetylcholine receptors (nAChRs) in CNS functi

218 ronic nicotine exposure is known to activate nicotinic acetylcholine receptors (nAChRs) in immune cel

219 , we studied cellular and circuit aspects of nicotinic acetylcholine receptors (nAChRs) in mouse STN.

220 The data suggest a complex interaction of nicotinic acetylcholine receptors (nAChRs) in regulating

221 sensitize high-affinity alpha4beta2 neuronal nicotinic acetylcholine receptors (nAChRs) in seconds.

222 X-12 over PhTX-343 for embryonic muscle-type nicotinic acetylcholine receptors (nAChRs) in TE671 cell

223 king results from the binding of nicotine to nicotinic acetylcholine receptors (nAChRs) in the brain,

224 Cigarette smoking leads to upregulation of nicotinic acetylcholine receptors (nAChRs) in the human

225 otine use induces functional upregulation of nicotinic acetylcholine receptors (nAChRs) in the mesoco

226 uced BPD and sought to ascertain the role of nicotinic acetylcholine receptors (nAChRs) in this respo

227 rents, showing that the assembled functional nicotinic acetylcholine receptors (nAChRs) included the

228 Study demonstrates that activation of nicotinic acetylcholine receptors (nAChRs) increases exc

229 Activation of nicotinic acetylcholine receptors (nAChRs) is associated

230 ulation of beta2 subunit-containing (beta2*) nicotinic acetylcholine receptors (nAChRs) is implicated

231 KEY POINTS: Neuronal nicotinic acetylcholine receptors (nAChRs) play a fundam

232 Nicotinic acetylcholine receptors (nAChRs) play a pivota

233 alpha7 nicotinic acetylcholine receptors (nAChRs) play an impor

234 Nicotinic acetylcholine receptors (nAChRs) play an impor

235 Blocking beta2 or alpha7 nicotinic acetylcholine receptors (nAChRs) prevents, res

236 actions, but very little is known about how nicotinic acetylcholine receptors (nAChRs) regulate LHb

237 ng the expression and clustering of neuronal nicotinic acetylcholine receptors (nAChRs) remain poorly

238 The agonist-binding site of nicotinic acetylcholine receptors (nAChRs) spans an inte

239 nduction of this form of LTP needs CP-alpha7 nicotinic acetylcholine receptors (nAChRs) that, like CP

240 Nicotine activates and/or desensitizes nicotinic acetylcholine receptors (nAChRs) throughout th

241 Nicotine binds directly to nicotinic acetylcholine receptors (nAChRs) to exert its

242 Here we show that SSS also antagonizes nicotinic acetylcholine receptors (nAChRs) to reduce syn

243 and impact of aging on presynaptic neuronal nicotinic acetylcholine receptors (nAChRs) within the ci

244 PG-PG interactions are modulated by nicotinic acetylcholine receptors (nAChRs), and our data

245 al homologs of the ligand-binding domains of nicotinic acetylcholine receptors (nAChRs), and they rep

246 tive allosteric modulator (PAM-II) of alpha7 nicotinic acetylcholine receptors (nAChRs), as long as 6

247 erienced by smokers are known to desensitize nicotinic acetylcholine receptors (nAChRs), but the impa

248 rette smoking leads to upregulation of brain nicotinic acetylcholine receptors (nAChRs), including th

249 epends on cholinergic tone and activation of nicotinic acetylcholine receptors (nAChRs), particularly

250 ne is a promising tracer for neuroimaging of nicotinic acetylcholine receptors (nAChRs), subtype alph

251 (DAergic) neurons via high-affinity neuronal nicotinic acetylcholine receptors (nAChRs), the mechanis

252 nists for the alpha(4)beta(2) subtype of the nicotinic acetylcholine receptors (nAChRs), we have synt

253 Nicotinic acetylcholine receptors (nAChRs), which are re

254 late-associated genes such as those encoding nicotinic acetylcholine receptors (nAChRs).

255 ting critical facets of brain maturation are nicotinic acetylcholine receptors (nAChRs).

256 eurotoxins that selectively inhibit neuronal nicotinic acetylcholine receptors (nAChRs).

257 s the alpha4-alpha4 interface of alpha4beta2 nicotinic acetylcholine receptors (nAChRs).

258 ptors (GABAARs) and inhibitors of excitatory nicotinic acetylcholine receptors (nAChRs).

259 nd potent antagonists of various subtypes of nicotinic acetylcholine receptors (nAChRs).

260 7a-aa) were designed as modulators of alpha7 nicotinic acetylcholine receptors (nAChRs).

261 d at higher concentration as an inhibitor of nicotinic acetylcholine receptors (nAChRs).

262 ontinued use is driven through activation of nicotinic acetylcholine receptors (nAChRs).

263 d additive actions through a family of brain nicotinic acetylcholine receptors (nAChRs).

264 -, alpha3alpha5beta4-, and alpha7-containing nicotinic acetylcholine receptors (nAChRs).

265 ure to Abeta in model nerve cells expressing nicotinic acetylcholine receptors (nAChRs).

266 Dysregulation of the neuronal nicotinic acetylcholine receptor (NNR) system has been i

267 Up-regulation of nicotinic acetylcholine receptors normalized before day

268 rment of synaptic transmission targeting the nicotinic acetylcholine receptor of muscle.

269 f nicotine dependence and stimulation of the nicotinic acetylcholine receptor on the ability to inter

270 sitivity and acute effects of stimulation of nicotinic acetylcholine receptors on behavioral and neur

271 survival in animal sepsis models via alpha7 nicotinic acetylcholine receptors on immunocompetent cel

272 t nicotine, acting through alpha7-containing nicotinic acetylcholine receptors on the postsynaptic ne

273 ion of Torpedo electrocyte membranes rich in nicotinic acetylcholine receptors on the surface of micr

274 )] called CHRFAM7A (gene-encoding dup-alpha7-nicotinic acetylcholine receptor) on a locus of chromoso

275 "spiroimidates") and their utility as alpha7 nicotinic acetylcholine receptor partial agonists are de

276 r behaviour in animals through inhibition of nicotinic acetylcholine receptors present in the central

277 age of the cholecystokinin-1 receptor or the nicotinic acetylcholine receptor reversed the protective

278 sphorylation of the ER-resident chaperone of nicotinic acetylcholine receptors, RIC-3, leads to incre

279 The alpha7 nicotinic acetylcholine receptor shows broad pharmacolog

280 by KYNA via presynaptic inhibition of alpha7-nicotinic acetylcholine receptor signaling.

281 Vc1.1 specifically and potently inhibits the nicotinic acetylcholine receptor subtype alpha9alpha10 (

282 ommon variants near the apolipoprotein E and nicotinic acetylcholine receptor subunit alpha 5 genes a

283 regulation of expression and function of the nicotinic acetylcholine receptor subunit cluster of alph

284 The Chrna5 gene encodes the alpha5 nicotinic acetylcholine receptor subunit, an "accessory"

285 Genes encoding the nicotinic acetylcholine receptor subunits alpha2 and bet

286 hat both common and rare variants of several nicotinic acetylcholine receptor subunits are associated

287 subregions of the IPN enriched for specific nicotinic acetylcholine receptor subunits.

288 active with ion channels of the ligand-gated nicotinic acetylcholine receptor superfamily (namely alp

289 Challenging examples are provided by nicotinic acetylcholine receptors that contain alpha7 ni

290 fic subtype of neuron, expressing non-alpha7 nicotinic acetylcholine receptors, that directly drives

291 resting conformation, and in skeletal muscle nicotinic acetylcholine receptors there is an exponentia

292 As agonists of nicotinic acetylcholine receptors, they disturb acetylch

293 amyloid-beta peptide (Abeta) engages alpha7 nicotinic acetylcholine receptors to induce release of a

294 In PAH RV samples, alpha-7 nicotinic acetylcholine receptor was increased and acety

295 f the anti-inflammatory alpha7-nAChR (alpha7-nicotinic acetylcholine receptor) was similar in young S

296 Lynx1, an endogenous inhibitor of nicotinic acetylcholine receptors, was previously shown

297 ed tool to probe the ion channel pore of the nicotinic acetylcholine receptor, which is a prototypica

298 lly, PrP(C)-STI1 engagement activated alpha7 nicotinic acetylcholine receptors, which participated in

299 unique cell types expressing alpha8 subunit nicotinic acetylcholine receptor, while SPO and cOv are

300 CK2: (a) the alpha and beta subunits of the nicotinic acetylcholine receptors with weak interaction,